Baolingbao Biology Co.,Ltd. (002286.SZ)
CNY 7.94
(-1.12%)
CNY 7.94
(-1.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 675.4 Million CNY | -32.58% |
| 2022 | 1 Billion CNY | -17.6% |
| 2021 | 1.21 Billion CNY | 19.62% |
| 2020 | 1.01 Billion CNY | 6.79% |
| 2019 | 951.76 Million CNY | -8.24% |
| 2018 | 1.03 Billion CNY | 78.29% |
| 2017 | 581.79 Million CNY | 37.4% |
| 2016 | 423.43 Million CNY | -2.76% |
| 2015 | 435.43 Million CNY | 37.49% |
| 2014 | 316.69 Million CNY | 31.48% |
| 2013 | 240.87 Million CNY | -18.43% |
| 2012 | 295.31 Million CNY | -16.12% |
| 2011 | 352.05 Million CNY | 6.86% |
| 2010 | 329.46 Million CNY | -21.84% |
| 2009 | 421.49 Million CNY | -16.68% |
| 2008 | 505.85 Million CNY | 23.8% |
| 2007 | 408.61 Million CNY | 3.34% |
| 2006 | 395.4 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 642.07 Million CNY | -3.39% |
| 2024 Q1 | 697.84 Million CNY | 3.32% |
| 2024 Q2 | 664.62 Million CNY | -4.76% |
| 2023 Q2 | 917.33 Million CNY | -4.96% |
| 2023 Q4 | 675.4 Million CNY | -10.64% |
| 2023 Q1 | 965.17 Million CNY | -3.66% |
| 2023 FY | 675.4 Million CNY | -32.58% |
| 2023 Q3 | 755.83 Million CNY | -17.61% |
| 2022 Q2 | 1.13 Billion CNY | 6.44% |
| 2022 Q4 | 1 Billion CNY | 4.23% |
| 2022 Q3 | 961.13 Million CNY | -15.34% |
| 2022 FY | 1 Billion CNY | -17.6% |
| 2022 Q1 | 1.06 Billion CNY | -12.27% |
| 2021 Q1 | 1.2 Billion CNY | 18.1% |
| 2021 FY | 1.21 Billion CNY | 19.62% |
| 2021 Q4 | 1.21 Billion CNY | 3.54% |
| 2021 Q3 | 1.17 Billion CNY | -5.13% |
| 2021 Q2 | 1.23 Billion CNY | 3.12% |
| 2020 Q4 | 1.01 Billion CNY | 14.43% |
| 2020 Q2 | 973.27 Million CNY | -6.19% |
| 2020 Q3 | 888.17 Million CNY | -8.74% |
| 2020 FY | 1.01 Billion CNY | 6.79% |
| 2020 Q1 | 1.03 Billion CNY | 9.01% |
| 2019 Q4 | 951.76 Million CNY | -5.57% |
| 2019 Q2 | 1.21 Billion CNY | 4.78% |
| 2019 FY | 951.76 Million CNY | -8.24% |
| 2019 Q1 | 1.15 Billion CNY | 11.59% |
| 2019 Q3 | 1 Billion CNY | -16.9% |
| 2018 Q4 | 1.03 Billion CNY | 12.41% |
| 2018 Q3 | 922.75 Million CNY | -10.21% |
| 2018 Q2 | 1.02 Billion CNY | 36.28% |
| 2018 FY | 1.03 Billion CNY | 78.29% |
| 2018 Q1 | 754.06 Million CNY | 29.61% |
| 2017 Q1 | 423.17 Million CNY | -0.06% |
| 2017 FY | 581.79 Million CNY | 37.4% |
| 2017 Q3 | 494.67 Million CNY | 3.8% |
| 2017 Q2 | 476.57 Million CNY | 12.62% |
| 2017 Q4 | 581.79 Million CNY | 17.61% |
| 2016 FY | 423.43 Million CNY | -2.76% |
| 2016 Q4 | 423.43 Million CNY | 2.84% |
| 2016 Q3 | 411.72 Million CNY | -3.25% |
| 2016 Q2 | 425.54 Million CNY | -4.53% |
| 2016 Q1 | 445.75 Million CNY | 2.37% |
| 2015 Q1 | 407.24 Million CNY | 28.59% |
| 2015 FY | 435.43 Million CNY | 37.49% |
| 2015 Q4 | 435.43 Million CNY | 13.1% |
| 2015 Q2 | 467.55 Million CNY | 14.81% |
| 2015 Q3 | 384.98 Million CNY | -17.66% |
| 2014 Q3 | 238.69 Million CNY | 9.7% |
| 2014 FY | 316.69 Million CNY | 31.48% |
| 2014 Q4 | 316.69 Million CNY | 32.68% |
| 2014 Q2 | 217.57 Million CNY | -6.72% |
| 2014 Q1 | 233.25 Million CNY | -3.16% |
| 2013 Q2 | 278.93 Million CNY | -8.52% |
| 2013 Q3 | 241.37 Million CNY | -13.47% |
| 2013 Q4 | 240.87 Million CNY | -0.2% |
| 2013 FY | 240.87 Million CNY | -18.43% |
| 2013 Q1 | 304.89 Million CNY | 3.25% |
| 2012 Q3 | 313.16 Million CNY | -15.95% |
| 2012 Q1 | 326.44 Million CNY | -7.28% |
| 2012 Q2 | 372.58 Million CNY | 14.14% |
| 2012 Q4 | 295.31 Million CNY | -5.7% |
| 2012 FY | 295.31 Million CNY | -16.12% |
| 2011 Q4 | 352.05 Million CNY | 5.68% |
| 2011 Q1 | 364.74 Million CNY | 10.71% |
| 2011 Q2 | 357.55 Million CNY | -1.97% |
| 2011 FY | 352.05 Million CNY | 6.86% |
| 2011 Q3 | 333.13 Million CNY | -6.83% |
| 2010 Q1 | 486.33 Million CNY | 15.38% |
| 2010 Q4 | 329.46 Million CNY | -16.69% |
| 2010 FY | 329.46 Million CNY | -21.84% |
| 2010 Q3 | 395.46 Million CNY | -1.28% |
| 2010 Q2 | 400.59 Million CNY | -17.63% |
| 2009 Q2 | 518.96 Million CNY | 0.0% |
| 2009 Q3 | 592.35 Million CNY | 14.14% |
| 2009 Q4 | 421.49 Million CNY | -28.84% |
| 2009 FY | 421.49 Million CNY | -16.68% |
| 2008 FY | 505.85 Million CNY | 23.8% |
| 2008 Q4 | 505.85 Million CNY | 0.0% |
| 2007 FY | 408.61 Million CNY | 3.34% |
| 2006 FY | 395.4 Million CNY | 0.0% |